Skip to main content

Peer Review reports

From: RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma

Original Submission
6 Mar 2017 Submitted Original manuscript
14 Jun 2017 Author responded Author comments - Dennis Harrer
16 Apr 2017 Reviewed Reviewer Report - Zong Sheng Guo
16 Apr 2017 Reviewed Reviewer Report - Yukai He
15 Apr 2017 Reviewed Reviewer Report - Xiaotao Jiang
Resubmission - Version 2
14 Jun 2017 Submitted Manuscript version 2
17 Jul 2017 Author responded Author comments - Dennis Harrer
Resubmission - Version 3
17 Jul 2017 Submitted Manuscript version 3
27 Jul 2017 Author responded Author comments - Dennis Harrer
Resubmission - Version 4
27 Jul 2017 Submitted Manuscript version 4
3 Aug 2017 Author responded Author comments - Dennis Harrer
Resubmission - Version 5
3 Aug 2017 Submitted Manuscript version 5
Publishing
10 Aug 2017 Editorially accepted
17 Aug 2017 Article published 10.1186/s12885-017-3539-3

You can find further information about peer review here.

Back to article page